Načítá se...
CAR-T cells and combination therapies: what’s next in the immunotherapy revolution?
Cancer immunotherapies are dramatically reshaping the clinical management of oncologic patients. For many of these therapies, the guidelines for administration, monitoring, and management of associated toxicities are still being established. This is especially relevant for adoptively transferred, ge...
Uloženo v:
| Vydáno v: | Pharmacol Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5828987/ https://ncbi.nlm.nih.gov/pubmed/29203440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2017.11.035 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|